Results 61 to 70 of about 11,328 (118)

Pandemia y Covid

REV SEN
Los pacientes hospitalizados por COVID-19 tienen mayor riesgo de lesión renal aguda (LRA, incidencia 0.5-80%), que contribuye a mayor morbimortalidad.
SLANH
doaj   +1 more source

2024 Annual Congress of the Pulmonary Vascular Research Institute

Pulmonary Circulation, Volume 14, Issue 2, April 2024.
wiley   +1 more source

Riñon, Diabetes y Metabolismo

REV SEN
En los ultimos 5 años el metabolismo relacionado al control de la diabetes mellitus tipo 2 y la nefropatía han dado un avance como no se había dislumbrado en decadas.
SLANH
doaj   +1 more source

Analysis of prevalence increase in different methods of renal function replacement treatment in Latin America

Revista de Nefrología, Diálisis y Trasplante, 2014
Introduction: The Latin American Dialysis and Renal Transplantation Registry (Latin American Society of Nephrology and Hypertension, SLANH) since 1991, has been collecting data on renal replacement therapy (RRT) whose prevalence increased from 335 to 576
María Carlota González-Bedat, Ana María Cusumano   +1 more
doaj  

Activación de código infarto en urgencias: manejo de IAMCEST en un paciente de 79 años con hipertensión reciente

Revista de Educaci�n e Investigaci�n en Emergencias
Francisco J. Martínez-Gutiérrez, Helen A. Martínez-Mendoza, Arath Güémez-Sánchez, Itari A. Sandoval-Villagómez, Iris L. Escobar-Muñoz   +4 more
openaire   +2 more sources

Early restrictive-constrictive physiology in a cardiac allograft recipient

Revista Portuguesa de Cardiologia, 2017
Carlos Ortiz-Bautista, Elena Puerto García-Martín, Laura Morán-Fernández, Inés Ponz-de Antonio, Adriana Rodríguez-Chaverri, Juan F. Delgado-Jiménez   +5 more
doaj   +1 more source

WCN24-2126 KIDNEY REPLACEMENT THERAPY IN LATIN AMERICA, 2021 DATA

Kidney International Reports
Guillermo Rosa-Diez, Rosario Luxardo, María Carlota González-Bedat, Alejandro Ferreiro, Maria Laura Ceretta   +4 more
doaj   +1 more source

[HEARTS Pharmacy: A framework for integrating pharmacists in hypertension and cardiovascular disease risk management in primary careFarmácia HEARTS: um modelo para a integração de farmacêuticos na gestão dos riscos de hipertensão arterial e doenças cardiovasculares na atenção primária]. [PDF]

Rev Panam Salud Publica
Ridley E, DiPette DJ, Gysel S, Rosende A, Campbell NRC, Neira Ojeda C, Pesenti R, Sanchez IC, Irazola V, Ruano Arevalo RH, López Olivares MP, Cortés Vidal D, Beltran Delgado M, Zurita J, Ordunez P.   +14 more
europepmc   +1 more source

[Expanding team-based care for hypertension and cardiovascular risk management with HEARTS in the AmericasAmpliação da atenção baseada em equipe para a gestão do risco de hipertensão arterial e doenças cardiovasculares com a iniciativa HEARTS nas Américas]. [PDF]

Rev Panam Salud Publica
Irazola V, Prado C, Rosende A, Flood D, Tsuyuki R, Ojeda CN, Reyes MV, Otero J, Wellmann IA, Fajardo I, Ridley E, Londoño E, Giraldo G, Bolastig E, Dias BM, Haeberer N, Ordunez P.   +16 more
europepmc   +1 more source

[HEARTS quality: a policy framework to strengthen hypertension and cardiovascular risk management in primary healthcare - insights from HEARTS in the AmericasQualidade da iniciativa HEARTS: marco de políticas para fortalecer o manejo da hipertensão e do risco cardiovascular na atenção primária à saúde. Perspectivas da iniciativa HEARTS nas Américas]. [PDF]

Rev Panam Salud Publica
Londoño E, Gupta R, Van der Stuyft P, Heine M, Giraldo G, Ku GM, Brettler J, Rosende A, Irazola V, Toelsie J, Neira C, Aumala T, Valdés Y, Zúñiga E, Rodríguez L, Villatoro M, Escobar MC, Pérez V, Bencomo A, Pereira M, de la Rosa A, Ordunez P.   +21 more
europepmc   +1 more source